Bolton LP’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bolton LP’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,100	Closed	-$112K	–	200
2015 Q2	$112K	Buy	+2,100	New	+$111K	0.03%	159

Other funds holding JUNO

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAMA

Graticule Asia Macro Advisors New York $1.33B AUM 1,044.61% 1-Year Est. Return

Bolton LP's JUNO Position: Q3 2015 in Review

Bolton LP sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2015, closing a stake of 25,700 shares — an estimated $1.37M sold.

Bolton LP first reported a position in JUNO in Q1 2015 and held it in 2 quarters. The position peaked at $1.37M in Q2 2015. 132 funds tracked by Wall St. Rank hold JUNO as of Q3 2015.

Bolton LP reported no remaining Juno Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
Bolton LP sold 25,700 Juno Therapeutics, Inc. shares in Q3 2015, an estimated $1.37M.
Bolton LP first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 2 quarters.
Bolton LP's Juno Therapeutics, Inc. position peaked at $1.37M in Q2 2015.
132 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2015.

Based on Bolton LP's 13F filing for Q3 2015, filed 16 Nov 2015.